TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34135056

Group type: EXPERIMENTAL
Intervention: Intraoperative wound irrigation with aqueous 10% povidone–iodine solution (40 mL for 1 min before skin suture)
Number of subjects: 950

Group type: COMPARATOR
Intervention: Normal saline (100 mL for 1 min before skin suture)
Number of subjects: 950
Study: 32134735

Group type: EXPERIMENTAL
Intervention: Serum zinc concentration measurement
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Zinc deficiency defined as serum zinc level < 75 μg/dL
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Age-sex specific reference percentile values for serum zinc
Number of subjects: 3500
Study: 33215197

Group type: EXPERIMENTAL
Intervention: Household contacts diagnosed with TB (cases)
Number of subjects: 1254

Group type: COMPARATOR
Intervention: Household contacts without TB diagnosis (controls)
Number of subjects: 1254
Study: 32081593

Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) applied on the experimental side on the 1st, 3rd, 5th, 7th, 14th and 15th days consecutively.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) at the end of canine retraction (4.5 months).
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 10
Study: 34326995

Group type: EXPERIMENTAL
Intervention: Community engagement (CE) activities with home-based sessions and village meetings
Number of subjects: 46614

Group type: COMPARATOR
Intervention: Control clusters (no community engagement activities)
Number of subjects: 46614
Study: 33225978

Group type: EXPERIMENTAL
Intervention: Shamiri group intervention
Number of subjects: 420

Group type: COMPARATOR
Intervention: Study-skills control intervention
Number of subjects: 420
Study: 36247106

Group type: EXPERIMENTAL
Intervention: Weekly group singing for 12 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Facilitated discussion group for 12 weeks
Number of subjects: 32
Study: 32049124

Group type: EXPERIMENTAL
Intervention: Bayesian hierarchical model
Number of subjects: 1758145
Study: 35012462

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) 5 mg daily for 4 days
Number of subjects: 297

Group type: COMPARATOR
Intervention: Sham patch
Number of subjects: 297
Study: 34010275

Group type: EXPERIMENTAL
Intervention: Inverted position with BFR
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inverted position without BFR
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Upright position with BFR
Number of subjects: 13

Group type: COMPARATOR
Intervention: Upright position without BFR
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 13
Study: 32998005

Group type: EXPERIMENTAL
Intervention: β-blockers (high-dose, medium-dose, low-dose)
Number of subjects: 6690

Group type: EXPERIMENTAL
Intervention: Medium-dose β-blockers
Number of subjects: 6690

Group type: EXPERIMENTAL
Intervention: Vasodilating β-blockers
Number of subjects: 6690
Study: 33944672

Group type: EXPERIMENTAL
Intervention: Maternal urine metabolomic analysis using mass spectrometry and nuclear magnetic resonance spectrometry
Number of subjects: 36

Group type: COMPARATOR
Intervention: Maternal urine metabolomic analysis
Number of subjects: 36
Study: 32740976

Group type: EXPERIMENTAL
Intervention: Experimental attention remediation treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 49
Study: 34694201

Group type: EXPERIMENTAL
Intervention: Duolingo (Spanish learning app)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: BrainHQ (brain training app)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 76
Study: 33006904

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitors (rtCGMs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 0
Study: 32483147

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei CBA L74-fermented formula
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 13

Group type: COMPARATOR
Intervention: Breastfeeding (reference group)
Number of subjects: 13
Study: 35331535

Group type: EXPERIMENTAL
Intervention: Green tea infusion with standardized breakfast
Number of subjects: 21

Group type: COMPARATOR
Intervention: Water with standardized breakfast
Number of subjects: 21
Study: 32696033

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of benzathine penicillin G
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intramuscular administration of benzathine penicillin G
Number of subjects: 15
Study: 33453467

Group type: EXPERIMENTAL
Intervention: CPR by foot
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard CPR (hands)
Number of subjects: 65
Study: 32423151

Group type: EXPERIMENTAL
Intervention: Ankle brace (AB)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (Cn)
Number of subjects: 33
Study: 33523368

Group type: EXPERIMENTAL
Intervention: Identification of 123 miRNAs classified into 63 families; stem-loop hairpin structures predicted.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stem-loop qRT-PCR for 25 randomly selected ain-miRNAs.
Number of subjects: 0
Study: 33320051

Group type: EXPERIMENTAL
Intervention: GLUCOSE+FRUCTOSE
Number of subjects: 9

Group type: COMPARATOR
Intervention: GLUCOSE ONLY
Number of subjects: 9
Study: 33417340

Group type: EXPERIMENTAL
Intervention: New carotid plaque
Number of subjects: 47

Group type: COMPARATOR
Intervention: CIMT progression
Number of subjects: 47
Study: 32023582

Group type: EXPERIMENTAL
Intervention: Fasting triglycerides
Number of subjects: 4988

Group type: EXPERIMENTAL
Intervention: Non-fasting triglycerides
Number of subjects: 4988
Study: 35368032

Group type: EXPERIMENTAL
Intervention: Prenatal professional breastfeeding education for the family
Number of subjects: 342

Group type: COMPARATOR
Intervention: Control group (no prenatal professional breastfeeding education)
Number of subjects: 342
Study: 34601832

Group type: EXPERIMENTAL
Intervention: Mobile health augmented cardiac rehabilitation (MCard) including counselling, brief text messages, and standard post-ACS care
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard post-ACS care (control group)
Number of subjects: 160
Study: 34081196

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOAC) treatment prior to lockdown
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOAC) treatment during lockdown
Number of subjects: 8
Study: 33840403

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Umbilical cord milking (UCM)
Number of subjects: 46
Study: 33419858

Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC)
Number of subjects: 461
Study: 33350619

Group type: EXPERIMENTAL
Intervention: 30° left‐lateral tilt position
Number of subjects: 75

Group type: COMPARATOR
Intervention: 15° left‐lateral tilt position
Number of subjects: 75

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 75
Study: 32060497

Group type: EXPERIMENTAL
Intervention: MedDiet + extra-virgin olive oil
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: MedDiet + nuts
Number of subjects: 889

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Weighted score of metabolites
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Baseline circulating concentrations of metabolites (hexose monophosphate, pyruvate, lactate, alanine, glycerol-3 phosphate, isocitrate)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: One-year increases in metabolites
Number of subjects: 889
Study: 36349675

Group type: EXPERIMENTAL
Intervention: Tinnitus Handicap Inventory‐China scale in exploration group (n = 565)
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: Tinnitus Handicap Inventory‐China scale in validation group (n = 564)
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: Content validity analysis in exploration group (n = 565)
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: Structural validity analysis in validation group (n = 564)
Number of subjects: 1129
Study: 32664149

Group type: EXPERIMENTAL
Intervention: Galgeun-tang (GGT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 33071012

Group type: EXPERIMENTAL
Intervention: Anthocyanins-rich Queen Garnet Plum juice
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (apricot juice)
Number of subjects: 16
Study: 32927849

Group type: EXPERIMENTAL
Intervention: Classroom Active Breaks (CABs) program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no CABs)
Number of subjects: 115
Study: 35761496

Group type: EXPERIMENTAL
Intervention: Simultaneous dual-task training (exercise and cognitive tasks), 24 sessions over 12 months, 60 mins per session
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (regular outpatient visits)
Number of subjects: 40
Study: 34245483

Group type: EXPERIMENTAL
Intervention: LAA orifice with chicken wing type
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oval LAA orifice
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: LAA orifice size and shape
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Endocardial surface roughness
Number of subjects: 200
Study: 32201198

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 111

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 111

Group type: COMPARATOR
Intervention: Preoperative N-terminal pro-brain natriuretic peptide
Number of subjects: 111
Study: 35785080

Group type: EXPERIMENTAL
Intervention: Empagliflozin combined with liraglutide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Liraglutide alone (Control)
Number of subjects: 50
Study: 34902081

Group type: EXPERIMENTAL
Intervention: Trichoderma asperellum (quality and organic seed-treatment products)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 3
Study: 34657873

Group type: EXPERIMENTAL
Intervention: McKenzie method (MDT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spiral Stabilization Method (SPS)
Number of subjects: 60
Study: 34711601

Group type: EXPERIMENTAL
Intervention: 16-week school-based behaviour change intervention consisting of health education, family involvement, and school environment support.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 64
Study: 32929107

Group type: EXPERIMENTAL
Intervention: Prolonged bedrest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resistive vibration exercise countermeasure during bedrest
Number of subjects: 0
Study: 33947295

Group type: COMPARATOR
Intervention: Risankizumab 150 mg/mL administered via prefilled syringe (PFS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg/mL administered via autoinjector (AI)
Number of subjects: 0
Study: 33694234

Group type: EXPERIMENTAL
Intervention: S. indica-inoculated plants
Number of subjects: 4

Group type: COMPARATOR
Intervention: Noninoculated control plants
Number of subjects: 4
Study: 35955123

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral smoking cessation treatment along with an App with active therapeutic components (SinHumo App)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive‐behavioral treatment along with the use of a control App (without active components)
Number of subjects: 0
Study: 33205991

Group type: EXPERIMENTAL
Intervention: Recommendation to wear masks (supply of 50 surgical masks and instructions for proper use)
Number of subjects: 3030

Group type: COMPARATOR
Intervention: No mask recommendation (control group)
Number of subjects: 3030
Study: 33176870

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (rTMS) for 5 sessions within 2 weeks duration
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham stimulation for 5 sessions within 2 weeks duration
Number of subjects: 76
Study: 35170843

Group type: EXPERIMENTAL
Intervention: Proximal optimization technique (POT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Kissing balloon technique (KBT)
Number of subjects: 120
Study: 36263927

Group type: EXPERIMENTAL
Intervention: Fosnetupitant 235 mg infusion
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Fosnetupitant (17.6–353 mg) infusion
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Fosnetupitant
Number of subjects: 158

Group type: COMPARATOR
Intervention: Oral NEPA
Number of subjects: 158
Study: 32020287

Group type: EXPERIMENTAL
Intervention: NIRF imaging using indocyanine green (ICG)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional hepatectomy
Number of subjects: 44
Study: 35046004

Group type: EXPERIMENTAL
Intervention: Gestational age method
Number of subjects: 454

Group type: COMPARATOR
Intervention: Nasal-tragus length (NTL) method
Number of subjects: 454
Study: 32504593

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy plus LDFRT (0.5 Gy twice daily for 2 days)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Induction chemotherapy alone
Number of subjects: 108
Study: 35755061

Group type: EXPERIMENTAL
Intervention: Height-based dosing algorithm of bupivacaine
Number of subjects: 280

Group type: COMPARATOR
Intervention: Constant dose of bupivacaine (Conventional group)
Number of subjects: 280
Study: 32150229

Group type: EXPERIMENTAL
Intervention: ECHO Autism program (12 sessions, 2 hours each, over 6 months)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: ECHO Autism program
Number of subjects: 148
Study: 35147294

Group type: EXPERIMENTAL
Intervention: Digital teaching method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 0
Study: 33452152

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 8056

Group type: COMPARATOR
Intervention: Non-statin users (Control)
Number of subjects: 8056
Study: 32442154

Group type: EXPERIMENTAL
Intervention: PD_manager system (mHealth platform including a wristband, sensor insoles, smartphone apps)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: PD_manager system (mHealth platform)
Number of subjects: 75
Study: 35139047

Group type: EXPERIMENTAL
Intervention: 10 minutes of electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 minutes of electrical stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 minutes of electrical stimulation (control)
Number of subjects: 0
Study: 34655135

Group type: EXPERIMENTAL
Intervention: FITOPROT (mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L.)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 32443322

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT) analysis of maxillary first premolars
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT) analysis of mandibular first premolars
Number of subjects: 648
Study: 35184319

Group type: EXPERIMENTAL
Intervention: Chan-Chuang qigong program
Number of subjects: 80
Study: 34119458

Group type: EXPERIMENTAL
Intervention: MVP (My Viva Plan) web-based application used for 12 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MVP (My Viva Plan) web-based application
Number of subjects: 32
Study: 32090748

Group type: EXPERIMENTAL
Intervention: SSRI+GZA
Number of subjects: 56

Group type: COMPARATOR
Intervention: SSRI+PBO
Number of subjects: 56
Study: 34590205

Group type: EXPERIMENTAL
Intervention: Self-management survivorship intervention
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147
Study: 32352644

Group type: EXPERIMENTAL
Intervention: Dapagliflozin up to 10 mg once daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metformin up to 1,000 mg twice daily
Number of subjects: 100
Study: 34251414

Group type: EXPERIMENTAL
Intervention: Cytarabine (100 mg/m2 per day on days 4-10) and Daunorubicin (60 mg/m2 per day on days 4-6) followed by Cytarabine consolidation (2000 mg/m2 per day on days 4-8) with G3139 (7 mg/m2 per day on days 1-10 for induction or days 1-8 for consolidation)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Cytarabine (100 mg/m2 per day on days 4-10) and Daunorubicin (60 mg/m2 per day on days 4-6) followed by Cytarabine consolidation (2000 mg/m2 per day on days 4-8) without G3139
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Cytarabine (100 mg/m2 per day on days 4-10) and Daunorubicin (60 mg/m2 per day on days 4-6) followed by Cytarabine consolidation (2000 mg/m2 per day on days 4-8) with G3139
Number of subjects: 506
Study: 36964526

Group type: EXPERIMENTAL
Intervention: Group Education (GE)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Person-Centered Support (PCS)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Group Education (GE) and Person-Centered Support (PCS)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 370
Study: 33451612

Group type: EXPERIMENTAL
Intervention: Computerized cardiotocography
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard cardiotocography (Control)
Number of subjects: 28
Study: 35271530

Group type: EXPERIMENTAL
Intervention: Virtual transvaginal ultrasonography
Number of subjects: 56

Group type: COMPARATOR
Intervention: In-clinic transvaginal ultrasonography
Number of subjects: 56
Study: 34664868

Group type: EXPERIMENTAL
Intervention: Carbohydrate group (400 mL carbohydrate drink 2 hours before surgery)
Number of subjects: 58

Group type: COMPARATOR
Intervention: NPO group (fast from midnight)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Carbohydrate group
Number of subjects: 58

Group type: COMPARATOR
Intervention: NPO group
Number of subjects: 58
Study: 33412771

Group type: EXPERIMENTAL
Intervention: Dermoscopy (DS)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Skin Scraping (SS)
Number of subjects: 144
Study: 35112455

Group type: EXPERIMENTAL
Intervention: Relaxing the UACR criterion from 300 mg/g to 210 mg/g
Number of subjects: 848

Group type: EXPERIMENTAL
Intervention: Flexible albuminuria and eGFR-based inclusion criteria
Number of subjects: 848
Study: 34048910

Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination rollout
Number of subjects: 0
Study: 35739541

Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 186
Study: 35746117

Group type: EXPERIMENTAL
Intervention: Physiotherapy based on the NDT Bobath concept
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classic exercises
Number of subjects: 60
Study: 33820541

Group type: EXPERIMENTAL
Intervention: Warming blanket and infusion thermometer
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Warming blanket and incubator
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (warming blanket only)
Number of subjects: 75
Study: 36190389

Group type: EXPERIMENTAL
Intervention: Exercises with blood flow restriction
Number of subjects: 28

Group type: COMPARATOR
Intervention: Exercises without blood flow restriction
Number of subjects: 28
Study: 34169526

Group type: EXPERIMENTAL
Intervention: Ruxolitinib (10 mg twice daily)
Number of subjects: 40
Study: 33307911

Group type: EXPERIMENTAL
Intervention: PariPEP S®
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acapella DH®
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Aerobika®
Number of subjects: 18
Study: 33861741

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (directly observed treatment)
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Usual care (referral for topical treatment)
Number of subjects: 1184
Study: 36462274

Group type: EXPERIMENTAL
Intervention: Hybrid simulation-based training
Number of subjects: 72

Group type: COMPARATOR
Intervention: Classical-based training
Number of subjects: 72
Study: 34388395

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (800 μg twice daily for 14 days)
Number of subjects: 4700

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4700
Study: 32962674

Group type: EXPERIMENTAL
Intervention: SIB-IMRT (60.62 Gy equivalent dose in 2-Gy fractions)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: SIB-IMRT + concurrent chemotherapy (weekly paclitaxel and a platinum-based drug for 5-6 weeks)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: SIB-IMRT + concurrent chemotherapy
Number of subjects: 164

Group type: COMPARATOR
Intervention: SIB-IMRT
Number of subjects: 164
Study: 35917698

Group type: EXPERIMENTAL
Intervention: Traffic-polluted Road exposure
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traffic-free Park exposure
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: TRAP exposure
Number of subjects: 35
Study: 35470974

Group type: EXPERIMENTAL
Intervention: E‐TRE+DCR (10-hour eating window starting within 3 hours of waking) plus DCR (35% DCR)
Number of subjects: 81
Study: 32841739

Group type: EXPERIMENTAL
Intervention: Buccal Micronucleus Cytome Assay (BMCyt)
Number of subjects: 804
Study: 33190559

Group type: EXPERIMENTAL
Intervention: DASH intervention
Number of subjects: 159

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 159
Study: 33077809

Group type: EXPERIMENTAL
Intervention: Dieting and behavioral interventions
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dieting
Number of subjects: 64
Study: 36220069

Group type: EXPERIMENTAL
Intervention: 8-hour time-restricted eating (TRE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of TRE and LCD
Number of subjects: 0
Study: 33279481

Group type: EXPERIMENTAL
Intervention: Ischemic heart disease (HFpEF patients with ischemia)
Number of subjects: 3445

Group type: COMPARATOR
Intervention: Nonischemic heart disease (HFpEF patients without ischemia)
Number of subjects: 3445

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 3445

Group type: EXPERIMENTAL
Intervention: Dyslipidemia
Number of subjects: 3445

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 3445

Group type: EXPERIMENTAL
Intervention: Revascularization (in ischemic HFpEF patients)
Number of subjects: 3445
Study: 32819394

Group type: EXPERIMENTAL
Intervention: Home-based contraceptive delivery (condoms, pills, injection, implant) during the routine 40-day postpartum visit.
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control clusters received comprehensive contraceptive counseling as part of routine care.
Number of subjects: 208
Study: 35796434

Group type: EXPERIMENTAL
Intervention: Employment programs (including skills-based training and hands-on placements)
Number of subjects: 5